Stage IV Prostate Carcinoma
1 clinical trials · Condition
◉ Watch Stage IV Prostate Carcinoma
| Record | Firm | Date |
|---|---|---|
| Dose Finding Safety Study of VAL201 in Cancer Patients (NCT02280317) | ValiRx Plc | 2014-10-01 |
Track Stage IV Prostate Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.